lysozyme

lysozyme. It is a ubiquitous glycoside hydrolase enzyme that catalyzes the hydrolysis of 1,4-beta-linkages between N-acetylmuramic acid and N-acetyl-D-glucosamine residues in peptidoglycan, a major structural component of the cell walls of Gram-positive bacteria. This enzymatic activity, often described as a "bacterial cell wall lytic enzyme," constitutes a fundamental component of the innate immune system across many species. First identified by Alexander Fleming in 1921, its discovery in human tears and egg white provided early insights into natural antimicrobial defenses.

Structure and mechanism

The three-dimensional structure of lysozyme, particularly from hen egg white, was determined through pioneering X-ray crystallography work by David Chilton Phillips and his team at the Royal Institution, marking it as one of the first enzymes and the first antibiotic protein to have its structure solved. The classic model features a prominent active site cleft that binds the polysaccharide substrate. The catalytic mechanism involves two key amino acid residues, glutamic acid 35 and aspartic acid 52, which work in concert to cleave the glycosidic bond via general acid-base catalysis. This "Phillips mechanism" was a landmark in enzymology, providing a clear structural basis for enzyme function. The enzyme's stability is bolstered by four disulfide bonds, a feature common in many secreted proteins.

Biological function and distribution

Lysozyme serves as a critical effector molecule in the first line of host defense. It is abundantly secreted in various bodily fluids, including tears, saliva, human milk, and mucus, and is found within the granules of neutrophils and macrophages. Its primary role is the lysis of susceptible bacteria, thereby protecting mucosal surfaces and contributing to phagocytosis. Beyond its direct antimicrobial action, lysozyme can kill bacteria through a non-enzymatic, cationic antimicrobial peptide-like mechanism, especially in environments like the stomach. It is widely distributed in the animal kingdom, found in species ranging from the phage T4 to mammals, and is also present in many plants and bacteria.

Medical and industrial applications

Due to its natural preservative and antimicrobial properties, lysozyme has significant applications in the food industry, where it is used to prevent late blowing defect in cheeses like Grana Padano and Parmigiano-Reggiano caused by Clostridium tyrobutyricum. In pharmaceuticals, it is employed as a natural antibacterial agent in products such as baby formula and wound care preparations. Clinically, elevated levels of lysozyme in serum or urine can serve as a biomarker for diseases involving monocyte or granulocyte turnover, such as sarcoidosis and certain leukemias. Research into engineered variants aims to enhance its activity against Gram-negative bacteria or HIV.

History and discovery

The enzyme was serendipitously discovered in 1921 by the Scottish bacteriologist Alexander Fleming, who observed that a drop of his own nasal mucus caused lysis of a bacterial culture on an agar plate. He named the substance "lysozyme" for its lytic action. His subsequent investigations, published in the Proceedings of the Royal Society B, detailed its presence in various tissues and fluids, including egg white, which became a major source for purification and study. This work preceded his more famous discovery of penicillin and established Fleming's early interest in natural antibacterial substances. The subsequent structural work by David Chilton Phillips in 1965 provided an atomic-level understanding of its function.

Genetics and biosynthesis

In humans, the lysozyme gene, designated LYZ, is located on chromosome 12. It encodes a pre-proenzyme that is processed into the mature, secreted protein. The human genome contains a single functional gene, while other species, like the domestic chicken, possess multiple isoforms. Expression is regulated in a tissue-specific manner, with high levels in myeloid cells and epithelial cells of secretory glands. Mutations in the LYZ gene are associated with hereditary systemic amyloidosis, where the protein forms insoluble amyloid fibrils in tissues, a condition studied extensively at the Boston University School of Medicine.

Category:Enzymes Category:Antimicrobial peptides Category:Immune system